Mutations and overexpression of ERB receptors (ERBB2 and ERBB3 in this network) have been strongly associated with more than 10 types of tissue-specific cancers and they can be seen at the highest level regulating most of the acyclic network. This evidence concerns the gene ERBB2 and cancer.